NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-143-2017-0-PCT-02 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range PCT PCT PCT/US2018/047876 Expired
NIAID E-236-2018-0-PCT-02 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof PCT PCT PCT/KR2018/009754 Expired
NCI E-139-2018-0-US-01 WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING US 62/721,986 Abandoned
NCI E-055-2011-0-US-05 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE US DIV 16/107,559 11357839 Issued PDF
NCI E-015-2011-0-US-12 NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER US DIV 16/107,532 10737995 Issued PDF
NCI E-291-2012-0-US-17 M971 CHIMERIC ANTIGEN RECEPTORS US DIV 16/107,271 10703816 Issued PDF
NEI E-077-2018-0-US-01 Metabolic Regulation Of Mitochondria To Inhibit Inflammatory Microglia In Treatment Of Axonal Injury And Neurodegenerations US 62/720,612 Abandoned
NEI E-165-2017-0-CN-03 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES CN National Stage 201880068155.5 Issued
NEI E-165-2017-0-PCT-02 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES PCT PCT PCT/US2018/047064 Expired
NCI E-767-2013-0-US-08 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules US CON 16/105,425 Abandoned
NIBIB E-006-2016-0-GB-10 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy GB EP 17844356.0 Abandoned
NIBIB E-006-2016-0-EP-03 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy EP National Stage 17844356.0 Abandoned
NIBIB E-006-2016-0-CH-07 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy CH EP 17844356.0 Abandoned
NIBIB E-006-2016-0-FR-09 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy FR EP 17844356.0 Abandoned
NIBIB E-006-2016-0-DE-08 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy DE EP 17844356.0 Abandoned
NIDDK E-132-2018-0-US-01 PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5'-NUCLEOTIDASE INHIBITORS US 62/719,492 Abandoned
NCI E-136-2018-1-AU-02 METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB AU National Stage 2017221268 Issued
NCI E-148-2011-0-EP-17 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer EP DIV 18188913.0 Issued
NCI E-148-2011-0-GB-46 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer GB EP 18188913.0 Issued
NCI E-148-2011-0-AT-40 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer AT EP 18188913.0 Issued
NCI E-148-2011-0-BE-41 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer BE EP 18188913.0 Issued
NCI E-148-2011-0-CH-42 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CH EP 18188913.0 Issued
NCI E-148-2011-0-ES-44 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer ES EP 18188913.0 Issued
NCI E-148-2011-0-IT-48 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IT EP 18188913.0 Issued
NCI E-148-2011-0-IE-47 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IE EP 18188913.0 Issued
NCI E-148-2011-0-DE-43 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer DE EP 18188913.0 Issued
NCI E-148-2011-0-NL-49 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer NL EP 18188913.0 Issued
NCI E-148-2011-0-PT-50 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PT EP 18188913.0 Issued
NCI E-148-2011-0-FR-45 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer FR EP 18188913.0 Issued
NHLBI E-175-2017-0-PCT-02 Hybrid CT System With Additional Detectors In Close Proximity To The Body PCT PCT PCT/US2018/046666 Expired
NCI E-136-2018-1-US-11 Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab US National Stage 16/077,720 Abandoned
NLM E-111-2016-7-JP-05 Novel CRISPR Enzymes And Systems JP National Stage 2018-561180 Abandoned
NLM E-110-2016-2-JP-05 Novel CRISPR Enzymes And Systems JP National Stage 2018-561179 Abandoned
NLM E-110-2016-2-CN-06 Novel CRISPR Enzymes And Systems CN National Stage CN PCT/US2016/038238 Pending
NLM E-111-2016-7-CN-06 Novel CRISPR Enzymes And Systems CN National Stage CN PCT/US2016/038258 Pending
NIAID E-064-2016-1-IN-06 SUBSTITUTIONS-MODIFIED PREFUSION RSV F PROTEINS
AND THEIR USE 		IN National Stage 201817030203 Issued
NLM E-111-2016-7-EP-04 Novel CRISPR Enzymes And Systems EP National Stage 16742455.5 Issued
NLM E-111-2016-7-DE-01 Novel CRISPR Enzymes And Systems DE EP 16742455.5 Issued
NLM E-111-2016-7-IS-01 Novel CRISPR Enzymes And Systems IS EP 16742455.5 Issued
NLM E-111-2016-7-IE-01 Novel CRISPR Enzymes And Systems IE EP 16742455.5 Issued
NLM E-111-2016-7-LU-01 Novel CRISPR Enzymes And Systems LU EP 16742455.5 Issued
NLM E-111-2016-7-LI-01 Novel CRISPR Enzymes And Systems LI EP 16742455.5 Issued
NLM E-111-2016-7-BE-01 Novel CRISPR Enzymes And Systems BE EP 16742455.5 Issued
NLM E-111-2016-7-SE-01 Novel CRISPR Enzymes And Systems SE EP 16742455.5 Issued
NLM E-111-2016-7-CH-01 Novel CRISPR Enzymes And Systems CH EP 16742455.5 Issued
NLM E-111-2016-7-NO-01 Novel CRISPR Enzymes And Systems NO EP 16742455.5 Issued
NLM E-111-2016-7-NL-01 Novel CRISPR Enzymes And Systems NL EP 16742455.5 Issued
NLM E-111-2016-7-FR-01 Novel CRISPR Enzymes And Systems FR EP 16742455.5 Issued
NLM E-111-2016-7-DK-01 Novel CRISPR Enzymes And Systems DK EP 16742455.5 Issued
NLM E-111-2016-7-FI-01 Novel CRISPR Enzymes And Systems FI EP 16742455.5 Issued